|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Stenotrophomonas maltophilia is increasingly being isolated as a nosocomial pathogen. It is the third most common non-fermenting gram negative bacilli (NFGNB) isolated from the clinical samples especially from the respiratory specimens, blood, urine and pus samples. Though inherently resistant to many groups of antibiotics, its susceptibility to co-trimoxazole is a peculiar character, because of which Co-trimoxazole is considered as the drug of choice for treating these infections. Recently there has been an increase in the incidence of resistance against Co-trimoxazole with variable resistance towards other antibiotics. In the present study 14.2% of the isolates were resistant to Co-trimoxazole. Resistant to other antibiotics was also very high. Ciprofloxacin and Chloramphenicol have shown reasonably good activity against this organism making these drugs as therapeutic alternatives in Co-trimoxazole resistant cases